Gilder Gagnon Howe & Co’s Dianthus Therapeutics DNTH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-44,076
| Closed | -$994K | – | 250 |
|
|
2022
Q3 | $994K | Sell |
44,076
-2,548
| -5% | -$57.5K | 0.02% | 198 |
|
|
2022
Q2 | $895K | Sell |
46,624
-164,867
| -78% | -$3.16M | 0.02% | 203 |
|
|
2022
Q1 | $9.81M | Sell |
211,491
-18,235
| -8% | -$846K | 0.09% | 142 |
|
|
2021
Q4 | $16.3M | Sell |
229,726
-5,946
| -3% | -$421K | 0.09% | 151 |
|
|
2021
Q3 | $27.5M | Sell |
235,672
-20,735
| -8% | -$2.42M | 0.14% | 135 |
|
|
2021
Q2 | $40.1M | Sell |
256,407
-5,431
| -2% | -$850K | 0.2% | 120 |
|
|
2021
Q1 | $49.6M | Sell |
261,838
-1,800
| -0.7% | -$341K | 0.27% | 100 |
|
|
2020
Q4 | $33.1M | Sell |
263,638
-2,942
| -1% | -$369K | 0.16% | 125 |
|
|
2020
Q3 | $29M | Sell |
266,580
-4,276
| -2% | -$465K | 0.18% | 119 |
|
|
2020
Q2 | $32.5M | Buy |
270,856
+17,119
| +7% | +$2.06M | 0.25% | 98 |
|
|
2020
Q1 | $25.5M | Sell |
253,737
-2,727
| -1% | -$274K | 0.31% | 92 |
|
|
2019
Q4 | $62.2M | Sell |
256,464
-2,703
| -1% | -$656K | 0.65% | 57 |
|
|
2019
Q3 | $42.5M | Sell |
259,167
-1,645
| -0.6% | -$270K | 0.49% | 66 |
|
|
2019
Q2 | $61.6M | Buy |
260,812
+146,485
| +128% | +$34.6M | 0.62% | 58 |
|
|
2019
Q1 | $30.1M | Buy |
+114,327
| New | +$30.1M | 0.32% | 80 |
|